3ANDERSEN G, VESTERGAAD K, INGEMANN-NIELSEN M, et al. Incidence of central poststroke pain[J]. Pain, 1995, 61: 187-193.
4ATFAL N, CRUCCU G, HAANPAA M, et al. EFNS guidelines on pharmacological treatment of neuropathic pain[J]. Eur J Neurol, 2006, 13(11): 1153-1169.
5BREIVIK H, BORCHGREVINK PC, ALLEN SM, et al. Assessment of pain[J]. Br J Anaesth, 2008, 101 ( 1 ) : 17-24.
6FRESE A, HUSSTEDT IW, RINGELSTEIN EB, et al. Pharmacologic treatment of central post-stroke pain[J]. Clin J Pain, 2006, 22(3): 252-260.
7HANSSON P. Post- stroke pain case study: clinical charac-teristics, therapeutic options and long-term follow-up[J]. Eur J Neurol, 2004, 11 Suppl 1: 22-30.
8PANDE AC, FELTNER DE, JEFFERSON JW, et al. Efficacy of the novel anxiolytic pregabalin in social anxiety disorder: a placebo-controlled, muhicenter study[J]. J Clin Psychopharmacol, 2004, 24(2): 141-149.
9PANDE AC, CROCKATT JG, FELTNER DE, et al. Pregabalin in generalized anxiety disorder: a placebo-controlled trial[J]. Am J Psychiatry, 2003, 160(3): 533-540.
10van SEVETER R, FEISTER HA, YOUNG JP, et al. Efficacy and tolerability of twice daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a week, randomized trial[J]. Curr Med Res Opin, 2006, 22(2) : 375-384.
